Cancelled due to Corona-virus. The meeting will be postponed to next year.

Friday 13^th November 2020

13:15      Welcome and introduction (D. Betticher, Fribourg)

Localized Colon Cancer (M. Hübner)

13:20      Complete mesocolic excision and D3 dissection: new standard of care? (D. Christoforidis, Lugano)

13:45      PRODIGE7, Colopeg, Prophylochip: Has HIPEC died? (M. Hübner, Lausanne)

14:10      Implications of liquid biopsies in resected colorectal cancer patients (T. Kössler, Genève)

14:35      HNPCC: diagnosis and practical implications (C. Weisshaupt, St. Gallen)

15:00      Interactive case presentations (U. Güller / M. Hübner)

15:30      Coffee break

Rectal cancer (C. Weisshaupt)

16:00      Neoadjuvant RT/CRT in locally advanced rectal cancer patients is the standard of care

              - Pro (O. Riesterer, Aarau)

              - Contra (M. Montemurro, Lausanne)

16:45      Surgical resection: Innovations and standard in 2020 (D. Hahnloser, Lausanne)

17:10      Watch and wait after neoadjuvant chemoradiation

              - The Dutch experience (G. Beets, Amsterdam)

              - Imaging (R. Beets-Tan, Amsterdam)

18:00      Interactive case presentations (U. Güller / M. Hübner)

18:30      Adjourn

Saturday 14^th November 2020

Advanced Colorectal cancer (U. Güller)

08:00      Duration of adjuvant chemotherapy: 3 or 6 months? (U. Güller, St. Gallen)

08:25      What is new in metastatic colorectal cancer? (A. Wicki, Liestal)

08:50      SIRT in advanced colorectal cancer: how and for whom? (L. Hechelhammer, St. Gallen)

09:15      Should we perform NGS panels in all patients with metastatic colorectal cancer? (D. Köberle, Basel)

09:40      Interactive case presentation (U. Güller / M. Hübner)

10:00      Coffee break

Small bowel, appendix (T. Kössler)

10:30      Appendiceal tumors: Entities and treatment modalities (K. Lehmann, Zürich)

10:55      Systemic treatment for small bowel adenocarcinoma: Treat as colon cancer, or differently? ( A. Digklia, Lausanne)

11:20      Treatment options in advanced neuroendocrine tumors of the small bowel (R. Winterhalder, Luzern)

11:50      Wrap up, feedback, award: best case presentation (U. Güller / M. Hübner)

12:15      End